Androteston

Quick links to important sections

Androteston

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Androteston

Property Description
Active ingredient Testosterone
Form Injectable Solution (Depot)
Pharmacological class Androgen and Anabolic Steroid
Common use Hormone Replacement Therapy (HRT)
Origin Synthetic (Bioidentical)

Androteston is a pharmaceutical preparation utilized for Hormone Replacement Therapy (HRT), providing the male sex hormone, Testosterone, to individuals with confirmed deficiency. The active substance, Testosterone, belongs to the Pharmacological class of Androgens and Anabolic Steroids. Its primary function is to act as a direct replacement for the body's endogenous steroid when its natural production is insufficient, a method widely clinically recognized for managing hormonal imbalances.


Defining Androteston: Identity and Pharmacological Classification

Androteston is medically defined as an Androgen and Anabolic Steroid, a categorization that reflects its dual function of inducing androgenic (masculinizing) and promoting anabolic (tissue-building) effects. The active ingredient is Testosterone, which is synthesized to replicate the structure of the natural hormone. This ensures a standardized, high-purity single-ingredient product focused on restoring deficient hormone levels. As an INN-based preparation, Androteston represents a formulation commonly available globally, sharing its core composition with other Testosterone ester products.


Composition, Physical Form, and Origin

The Injectable Solution form of Androteston is typically an Oil-Based Ester Solution, commonly utilizing a long-acting ester such as Testosterone Enanthate or Testosterone Cypionate. This formulation is designed for Intramuscular (IM) injection and is specifically a Depot Injection. The design uses an oleaginous vehicle to facilitate sustained-release. This property is a key differentiating factor from daily topical preparations, helping to maintain stable, therapeutic hormone concentrations with less frequent patient intervention.


General Purpose: Why is Androteston Used?

The general purpose of administering Androteston is to correct the clinical condition of Testosterone deficiency, often referred to as Hypogonadism. By supplying the necessary male sex hormone, the medication supports the maintenance of essential physiological functions. This action helps ensure the preservation of muscle mass, bone density, and male secondary sexual characteristics, thereby supporting overall physical structure and well-being in patients with a confirmed hormonal imbalance.

Regulatory References

  1. MedlinePlus Testosterone Enanthate Information

What side effects are possible with Androteston?

Possible Side Effects and Safety Information

The safety profile of Androteston (Testosterone Injectable Solution) is based strictly on classifications documented in official government regulatory sources, such as the FDA and EMA. Adverse reactions are grouped by the physiological system affected and by their frequency of occurrence.

Official Adverse Reaction Categories

Side effects are categorized by frequency as defined in regulatory documents:

  • Very Common: Officially listed reactions occurring in this category include an increase in hematocrit, an increase in red blood cell count, and an increase in hemoglobin. These effects relate to the blood and lymphatic system and require regular monitoring.
  • Common: Reactions classified as common include polycythaemia (high red blood cell count), headache, hot flushes, acne, alopecia (hair loss), gynecomastia (male breast enlargement), prostate enlargement (Benign Prostatic Hyperplasia), and an increase in Prostatic Specific Antigen (PSA). Injection site pain is also a common local reaction.

Serious Adverse Reactions and Safety Constraints

The official labeling documents certain serious adverse reactions. These include the potential for venous thromboembolism (VTE), which encompasses deep vein thrombosis (DVT) and pulmonary embolism (PE). Caution is advised as fluid retention (edema) can occur, which may potentially lead to congestive heart failure in patients with pre-existing severe cardiac, hepatic, or renal conditions. Androteston is contraindicated in males with known or suspected prostate or male breast carcinoma.

Population-Specific Safety Notes

The safety profile includes constraints for specific groups. For geriatric patients, there is an increased documented risk of prostatic hypertrophy and prostatic carcinoma. In prepubertal boys, the use of this medicine may lead to accelerated bone maturation, potentially compromising final adult stature.

Overdose and Emergency Response

The official regulatory documents state that an overdose of Androteston, or high-dose exposure, is generally managed by the immediate discontinuation of therapy as no specific antidote is known. The clinical presentation of overexposure includes exaggerated androgenic effects such as Priapism (excessive erections) and Gynecomastia, alongside non-specific systemic manifestations like Nervousness, Irritability, Nausea, and fluid retention leading to Edema.

The regulatory profile highlights severe, life-threatening outcomes that mandate urgent intervention. These include serious Venous Thromboembolic Events (VTE), such as Deep Vein Thrombosis and Pulmonary Embolism. Furthermore, patients with pre-existing cardiac, renal, or hepatic disease are at increased risk for severe Edema that may progress to Congestive Heart Failure. Rare but severe hepatic complications, including Peliosis Hepatis and Hepatocellular Carcinoma, are documented risks associated with high-dose use.

The labels explicitly state that immediate medical attention must be sought for acute symptoms, including chest pain, trouble breathing, slurred speech, or sudden weakness in one side of the body, as these may indicate a Myocardial Infarction or Stroke. Management focuses on providing symptomatic and supportive treatment.

Therapeutic Uses of Androteston

Quick Facts: Primary Therapeutic Domains

  • Approved Use: Hormone replacement for conditions associated with deficient or absent testosterone, specifically male hypogonadism.
  • Focus Areas: Support for secondary male characteristics, bone density, and maintenance of muscle mass in affected individuals.
  • Symptom Support: May assist in managing symptoms such as low libido, reduced spontaneous erections, and diminished energy levels associated with hypogonadism.

Androteston is an approved formulation used as replacement therapy for males diagnosed with conditions linked to low or absent endogenous testosterone. This is primarily indicated for confirmed male hypogonadism resulting from specific medical causes.

Therapeutic use aims to support the restoration of circulating testosterone concentrations to an established range. This replacement process may assist in the maintenance of secondary sex characteristics, red blood cell production, and support for bone density.

For men with documented hypogonadism, Androteston may also offer support in managing certain associated symptoms, which can include decreased libido, reduced sexual function, and diminished energy and mood. It is important to note that the effectiveness and safety of testosterone products have not been established for men with low testosterone due to natural aging.

Prescription testosterone products are indicated only for men who have low testosterone levels caused by certain medical conditions, such as primary or secondary hypogonadism.

Eligibility and Restrictions for Use

Who Can and Cannot Use Androteston?

The population eligibility for Androteston (Testosterone Injectable Solution) is strictly defined by regulatory authorities and is confined to replacement therapy for adult males with a confirmed diagnosis of Hypogonadism (testosterone deficiency).


Absolute Contraindications (Must Not Use)

Population Group Regulatory Status
Males with Carcinoma of the Breast or Prostate Contraindicated
Women (especially Pregnant or Nursing women) Contraindicated / Not Indicated
Patients with Known Hypersensitivity Contraindicated

Conditional Use and Age Limitations

Population Group Regulatory Status / Restriction
Severe Cardiac, Hepatic, or Renal Insufficiency Use is Contraindicated or requires immediate cessation due to oedema risk.
Men with low testosterone due to Aging Alone Safety and Efficacy Not Established (Use Not Indicated).
Pediatric Population (under 18) Not Indicated; efficacy and safety not established.
Geriatric Patients (over 65) Limited Data; requires frequent prostate monitoring.

All patients must have their hypogonadism confirmed by both clinical signs and multiple laboratory tests prior to use.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Androteston (Testosterone) interacts with several medication classes, resulting in officially documented pharmacokinetic and pharmacodynamic outcomes, as detailed in regulatory labeling.


Documented Pharmacodynamic Interactions

These interactions involve a change in the drug's effect without altering its concentration:

  • Corticosteroids (e.g., Prednisone): Co-administration may result in increased fluid retention (edema). This risk requires particular caution in patients with pre-existing cardiac, renal, or hepatic disease, as noted in regulatory documents.
  • Antidiabetic Agents (e.g., Insulin, Oral Hypoglycemics): Androgens may decrease blood glucose levels, which potentiates the effects of antidiabetic agents, potentially necessitating a reduction in their dosage.
  • Medications Known to Increase Blood Pressure: Concomitant use may lead to additional increases in blood pressure.

Documented Pharmacokinetic Interactions

These interactions affect how the body processes the medicine:

  • Oral Anticoagulants (Coumarin derivatives, e.g., Warfarin): Androgens may increase sensitivity to the anticoagulant, potentiating its effect. This mandates more frequent monitoring of International Normalized Ratio (INR) and prothrombin time, and often requires a dose reduction of the anticoagulant.
  • Enzyme Inducers (e.g., Barbiturates): These substances may cause increased clearance of testosterone, potentially reducing its exposure.
  • Oxyphenbutazone: Concurrent use has been reported to result in elevated serum levels of Oxyphenbutazone.

Mechanism of Action

How Androteston Works: Mechanism of Action

Androgen Receptor Agonism and Anabolic Signaling

This domain covers the primary biological action where the drug or its active metabolites bind to the Androgen Receptor (AR) inside cells, acting as an agonist. This interaction initiates a genomic cascade that supports the transcription of anabolic genes, directly influencing muscle protein synthesis and bone mineralization processes.

Pro-Hormonal Pathway Integration

This mechanism involves the drug being integrated into the body's steroid biosynthesis pathways. It functions as a precursor that is subject to conversion by endogenous enzymes (like 5alpha -reductase and aromatase) into more potent androgens and estrogens. This results in the systemic co-modulation of the androgenic and estrogenic systems, influencing the resultant physiological responses.

Neuro-modulation via GABA A Receptors

A crucial metabolite of Androteston acts centrally by crossing into the brain to become a Positive Allosteric Modulator of the inhibitory GABA A receptor. This action enhances GABAergic signaling, directly influencing the Central Nervous System. This mechanistic path contributes to the central nervous system responses associated with mood and behavior.

Dosage and Administration Information

Administration and Usage

Androteston is a pharmacological preparation of testosterone designed for systemic administration. The application of this medication is typically managed within a clinical framework to ensure appropriate therapeutic levels are maintained. The specific method of administration, whether through intramuscular injection or other delivery systems, depends on the pharmaceutical form prescribed.

General Considerations for Use

The usage of Androteston is dictated by the individual's clinical requirements. Consistency in the timing of administration is often emphasized to maintain stable physiological concentrations of the hormone. When utilizing this medication, it is standard practice to follow the specific protocol established by a healthcare professional, as the frequency and duration of use are tailored to the underlying condition being addressed.

Preparation and Handling

Proper handling of the medication involves ensuring the integrity of the packaging before use. If the product is an injectable solution, it should be visually inspected for clarity and the absence of particulate matter. The storage environment plays a critical role in maintaining the stability of the active compound, generally requiring protection from light and extremes of temperature.

Therapeutic Context

Androteston is used as a replacement or supplemental therapy in instances where endogenous testosterone production is insufficient. Monitoring progress involves regular clinical assessments to evaluate the physiological response to the medication. Users are typically advised to remain observant of any changes during the course of their regimen and to maintain open communication with their healthcare provider regarding the ongoing application of the therapy.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Androteston


Evidence for Use in Confirmed Male Hypogonadism

The official clinical evaluation of Androteston was evaluated in research exploring how symptoms change over time in adult men with a confirmed testosterone deficiency, also known as hypogonadism. The research primarily involved short-term Randomized Controlled Trials (RCTs), along with systematic reviews and meta-analyses. This evidence base applied in studies examining patient-reported experiences of this condition.

The research examined outcomes related to physical discomfort and outcomes related to systemic or functional imbalance. Studies explored how circulating testosterone concentrations moved into the physiological range for the observed populations. Trials monitored patient-reported changes in sexual desire and erectile function scores. Research examined physical structure, with studies describing measurements of lean body mass (muscle) and fat mass over the course of the study period.

Outcomes Studied in Hypogonadism Trials

Studies monitored several specific physical and symptomatic measures. Researchers evaluated outcomes reflecting daily functioning or activity level, such as subjective vitality and fatigue levels, often through patient-reported questionnaires. Longer-term data contribute to understanding symptom patterns related to changes in bone mineral density ( BMD), particularly in the lumbar spine, observed in men who completed treatment protocols. This research describes patterns observed in the studied population.


Evidence Landscape: Long-Term Studies and Follow-up

The majority of high-quality RCTs for this therapy have follow-up durations that were limited, often lasting less than one year. Research monitored these short-term symptom changes. Because of this, the long-term effects are not fully established, and evidence regarding the sustained outcomes of treatment largely comes from observational settings evaluating daily-life functioning, such as extended prospective registries. These registries contribute to the broader evidence landscape by exploring how symptoms may vary in intensity over the course of many years of replacement therapy.


What the Research Still Shows is Uncertain About Androteston

A primary limitation in the research is the short follow-up duration of many controlled trials, meaning there is limited information for long-term outcomes. Additionally, subgroup findings are uncertain when trying to generalize results to all men with deficiency, as evidence quality varies across studies due to differences in trial design and patient inclusion criteria. Findings related to some non-specific outcomes, such as changes in physical strength or certain cognitive measures, have been mixed, where certainty remains low. The regulatory evidence landscape contributes to understanding symptom patterns and points out that data are still emerging regarding extended physiological effects.

Frequently Asked Questions (FAQ)

Common questions about Androteston (FAQ)


Q: Does Androteston affect mood or sleep?

A: Official safety information indicates that adverse reactions affecting the central nervous system have been reported, which include changes to mood, nervousness, or aggression. While the medicine influences mood, changes to sleep patterns like insomnia are not typically listed among the common side effects.

Q: Can I take Androteston if I have high blood pressure?

A: Official labeling does not state that uncomplicated high blood pressure (hypertension) is an absolute contraindication for use. However, regulatory documents caution that the medicine may potentially increase blood pressure and is associated with increased risk in patients who have pre-existing cardiac conditions.

Q: Is Androteston known to cause weight gain or fluid retention?

A: Fluid retention, known as oedema, is a documented adverse reaction and a key safety warning, especially for patients with pre-existing heart, liver, or kidney problems. Conversely, weight gain is not explicitly listed as a common or very common side effect in the official frequency categories.

Q: How long can a person safely use Androteston?

A: Official documentation points out that the long-term safety and efficacy of the product, particularly regarding extended cardiovascular outcomes, have not been fully established in controlled clinical studies. Therefore, evidence for the sustained outcomes of treatment largely comes from long-term observational data.

Q: What is the expected duration of treatment with Androteston?

A: According to regulatory sources, this medicine is indicated for hormone replacement therapy to address a confirmed deficiency. Treatment is typically ongoing, continuing for as long as the underlying hormonal imbalance persists and the medicine is well tolerated.

Q: What are the signs of a serious, but rare, side effect from Androteston?

A: Official patient information describes the key signs of serious, though rare, safety issues such as venous thromboembolism (VTE) to aid patient awareness regarding potentially serious symptoms. These signs may include sudden shortness of breath or chest pain (pulmonary embolism), or pain, swelling, and redness in the leg (deep vein thrombosis).

Q: Do patients typically feel different immediately after starting Androteston?

A: The injectable form of Androteston is a depot formulation, meaning it is specifically designed for sustained release of the active ingredient over a period of several weeks. Because of this design, the concentration of the hormone in the body is not expected to peak immediately after administration.

Q: How fast does Androteston start working?

A: Androteston is a long-acting depot injection that releases the active ingredient slowly into the body over several weeks. Therefore, the full clinical effect of the medicine is typically not observed or assessed until after several weeks or months of consistent therapy.

Q: Are there any common foods or supplements that interact with Androteston?

A: Regulatory labeling focuses on documented interactions with other prescription and over-the-counter medicines. Official documents do not typically list specific interactions with common foods or general nutritional supplements.

Q: What happens if I stop taking Androteston suddenly?

A: Abrupt cessation of replacement therapy is likely to result in the return of symptoms associated with the underlying testosterone deficiency. Specific regulatory instructions regarding tapering off the medicine or managing withdrawal effects are not commonly detailed in the label.

Q: What is the risk of developing dependence on Androteston?

A: The official labeling documents that the medicine has the potential for abuse and for developing physical or psychological dependence. This risk is primarily associated with use at dosages higher than those prescribed for hormone replacement therapy.

Q: Will Androteston show up on a standard drug test?

A: Since the active ingredient in the medicine is Testosterone, an endogenous hormone, its presence or high concentration can be detected in various drug tests. Its presence may be relevant in contexts where regulatory bodies restrict the use of androgens.

Q: Does Androteston interact with birth control pills?

A: Testosterone may alter the metabolism of certain hormones in the body. For this reason, official regulatory documents generally advise that caution is necessary when combining androgens with other hormonal products, including birth control pills.

Q: What does 'contraindicated' mean for Androteston?

A: In official medical documents, a contraindication means that the medicine is strictly prohibited and must not be used in patients who have certain specified conditions. This is because the risk of use is judged to be higher than any potential therapeutic benefit.

Q: Can I take ibuprofen or aspirin while using Androteston?

A: Regulatory information explicitly lists interactions with oral anticoagulants (blood thinners) such as warfarin. While specific common pain relievers are not always listed, official documents highlight the need for careful monitoring with any medication that affects blood clotting.

Q: Does Androteston have a risk evaluation and mitigation strategy (REMS)?

A: Certain injectable testosterone products have been subject to a US Food and Drug Administration (FDA) mandated Risk Evaluation and Mitigation Strategy (REMS) program. This strategy requires specific safety measures and communication due to the presence of serious risks.

Q: Can Androteston affect fertility?

A: Official labeling documents that the medicine may have an inhibitory effect on spermatogenesis (the process of creating sperm). This effect may result in a negative impact on a patient's fertility.

Q: Is the name Androteston a brand name or a generic name?

A: The active ingredient is Testosterone, which is the generic chemical name for the hormone. The name Androteston represents a specific product or brand formulation of a testosterone ester developed for regulated marketing.

Q: Is Androteston considered a controlled substance?

A: Yes, as a testosterone product, this medicine is designated by regulatory agencies as a controlled substance (e.g., Schedule III in the US) due to its potential for abuse and is regulated by specific rules for prescribing and dispensing.

Q: What happens if a dose of Androteston is missed?

A: Standard regulatory patient instructions indicate that a patient should seek guidance if a dose is missed. Regulatory documents state that schedule adjustments to maintain the therapeutic level typically require consultation with a healthcare provider.

Q: Does alcohol consumption affect how Androteston works?

A: Official patient information mentions that alcohol consumption should be limited or avoided while using this medicine. Alcohol may potentially influence how the body metabolizes the hormone, specifically affecting liver function.

Q: Are there any known interactions between Androteston and herbal remedies?

A: Regulatory labeling requires that a patient's complete list of herbs and supplements be reviewed with a healthcare provider. The interaction risk with non-regulated herbal remedies is often unknown because they have not been formally studied alongside the medicine.

Q: Can Androteston cause vision changes?

A: Official documents list fluid retention (oedema) as a known side effect. In rare instances, severe fluid retention has been reported to cause temporary visual disturbances due to changes in pressure inside the skull.

Q: Is a patient information leaflet (PIL) available for Androteston?

A: Yes, government regulatory agencies require that a standardized Patient Information Leaflet (PIL) or Medication Guide be provided to the patient. This document must accompany the medicine at the time of dispensing.

Q: How does the FDA classify the safety of Androteston?

A: The safety classification is defined by its designation as a Controlled Substance (e.g., Schedule III in the US) and its strict prohibition in women due to the risk of harm to a developing fetus.

Q: Can taking Androteston cause changes in cholesterol levels?

A: Official documentation warns that treatment with androgens may alter a patient's lipid profile, including the levels of cholesterol and triglycerides. The potential for these changes is one reason why blood work is monitored during therapy.

Q: Is it safe to drive or operate machinery after using Androteston?

A: According to the official labeling for this class of medicine, there is generally no or negligible effect on the ability of the patient to drive or safely operate heavy machinery.

Q: Does Androteston require a special prescription process?

A: Yes, because the medicine is classified as a controlled substance, it is subject to specific federal and state regulations. This requires a special prescription process regarding prescribing, record-keeping, and dispensing.

Q: Can I donate blood while I am taking Androteston?

A: Since the medicine commonly causes an increase in hematocrit and red blood cell count, blood donation centers may require temporary deferral. Eligibility to donate will be determined by the center based on blood test results and current standards.

Q: Is Androteston known to interact with common pain relievers?

A: Regulatory text explicitly lists documented interactions with oral anticoagulants (blood thinners). Official documentation requires that all co-administered medications, including common pain relievers, be discussed with a healthcare provider.

How should Androteston be stored and disposed of?

Storage and Disposal of Androteston (Testosterone Injection)

The official labeling defines specific conditions for storing Androteston, an injectable testosterone product, to maintain its stability and quality.

Official Storage Conditions

  • Temperature and Light: The medicine must be stored at a Controlled Room Temperature between 20 C and 25 C (68 F to 77 F). The container must also be protected from light.
  • Handling: The solution should not be frozen. If crystallization occurs due to cold exposure, the vial must be warmed and rotated to redissolve the crystals before use. The solution should be visually inspected for particles.
  • Security: As required by regulation, the medicine must be kept out of the sight and reach of children.

Disposal Instructions

  • Unused Product: Any portion remaining in a single-dose vial after use must be discarded immediately.
  • Waste Handling: The product and its container must be disposed of through an appropriate treatment and disposal facility in accordance with local regulations, and must not be discharged into sewer systems.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Androteston found in:

A-Z Index: